افسردگی و عوامل مرتبط با آن در بیماران مبتلا به پوکی استخوان

نوع مقاله : مقاله پژوهشی

نویسندگان

1 گروه روانشناسی، دانشگاه آزاد اسلامی، واحد اهر، اهر، ایران

2 مرکز تحقیقات ارتوپدی ، دانشگاه علوم پزشکی مازندران،ساری، ایران

3 مرکز تحقیقات روانپزشکی و علوم رفتاری، پژوهشکده اعتیاد؛ دانشگاه علوم پزشکی مازندران، ساری، ایران

4 مرکز تحقیقات ارتوپدی، دانشگاه علوم پزشکی مازندران، ساری، ایران

5 مرکز تحقیقات ارتوپدی، بیمارستان امام خمینی (ره)، دانشگاه علوم پزشکی مازندران، ساری، ایران.

10.22034/ijos.2025.546106.1159
چکیده
چکیده:
مقدمه: پوکی استخوان در حال حاضر یک مشکل بهداشت عمومی بوده و به‌عنوان بیماری خاموش قرن شناخته می‌شود. عوارض پوکی استخوان بر زندگی افراد تأثیر گذاشته و منجر به اضطراب و افسردگی می‌شود؛ بنابراین هدف اصلی مطالعه حاضر، تعیین فراوانی علائم افسردگی و عوامل مرتبط با آن در این بیماران است.
مواد و روش‌ها: پژوهش حاضر یک مطالعه مقطعی-تحلیلی است که بر روی 35 بیمار مبتلا به پوکی استخوان که در سال 1403 به کلینیک پوکی استخوان بیمارستانی آموزشی مراجعه کرده بودند انجام شد. اطلاعات بیماران با استفاده از یک چک‌لیست محقق ساخته و پرسشنامه اضطراب و افسردگی هاسپیتال جمع‌آوری شدند. تحلیل‌های آماری با استفاده از نرم‌افزار 20 SPSS در سطح معنی‌داری 05/0 انجام شد.
نتایج و بحث: از 35 بیمار مورد مطالعه، در 24 (57/68 درصد) بیمار علائم افسردگی مشاهده شد. 32 (40/91 درصد) بیمار زن و 3 (60/8 درصد) بیمار نیز مرد بودند. علائم افسردگی در 60/65 درصد از زنان و همه مردان مشاهده شد. میانگین سنی کلی بیماران 80/6 86/63 سال بود. 7 (70/46 درصد) نفر از بیماران مبتلا به دیابت و 17 (00/85 درصد) نفر از بیماران بدون دیابت علائم افسردگی داشتند و ارتباط آماری معناداری بین دیابت و علائم افسردگی در این بیماران مشاهده شد (05/0 < P)؛ اما ارتباط آماری معناداری بین سایر متغیرها با علائم افسردگی یافت نشد (05/0 > P).
نتیجه‌گیری: یافته‌های حاصل از مطالعه حاضر نشان داد که فراوانی علائم افسردگی در بیماران مبتلا به پوکی استخوان بالا است از این رو بایستی به عنوان یک عامل مهم در درمان پوکی استخوان در نظر گرفته شود.

کلیدواژه‌ها

موضوعات

عنوان مقاله English

Depression and Associated Factors in Patients with Osteoporosis

نویسندگان English

Shiva Momeni 1
mohamadmohsen hoseinian 2
Asieh Katouk 3
Seyedeh Masoumeh Hoseini Marzroudi 4
isa nazar 5
1 Psychology Department, Islamic Azad University, Ahar Branch, Ahar, Iran.
2 orthopedic research center,Mazandaran university of medical science,,sari ,iran
3 Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
4 Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
5 Orthopedic Research Center, Mazandaran University of Medical Science, Sari, Iran
چکیده English

Abstract
Introduction: Osteoporosis is currently a public health problem and is known as the silent disease of the century. The complications of osteoporosis affect people's lives and lead to anxiety and depression. The main purpose of our study is to determine the frequency of depressive symptoms and related factors in patients with osteoporosis.
Materials & Methods: The present study is an analytical cross-sectional study that was conducted on 35 patients with osteoporosis who referred to the osteoporosis clinic of a teaching hospital between March 2024 and March 2025. Patient information was gathered using a researcher-made checklist and the Hospital Anxiety and Depression (HADS) questionnaire. All statistical analyses were performed using SPSS 20 software at a significance level of 0.05.
Results & Discussion: Out of the 35 patients studied, 24(68.57%) exhibited depressive symptoms. Of these, 32(91.40%) were female, and 3(8.60%) were male. Depressive symptoms were observed in 65.60% of women and in all men. The overall mean age of the patients was 63.86±6.80 years. Among the patients, 7(46.70%) with diabetes and 17(85.00%) without diabetes had depressive symptoms, showing a statistically significant link between diabetes and depressive symptoms in osteoporosis patients (P<0.05). However, no statistically significant association was found between other variables and depressive symptoms in patients with osteoporosis (P>0.05).
Conclusion: The findings of the present study suggests that the frequency of depressive symptoms is high in patients with osteoporosis; therefore, it should be considered as an important factor in the treatment of osteoporosis.

کلیدواژه‌ها English

Osteoporosis
Depression
Densitometry
1         Kanis J, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporosis international. 2000;11:669-674. https://doi.org/10.1007/s001980070064
2         WA P. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646-650.
3         Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, et al. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporosis international. 1999;10(4):259. DOI:10.1007/s001980050224
4         Rossini M, Adami S, Bertoldo F, Diacinti D, Gatti D, Giannini S, et al. Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo. 2016;68(1):1-39. DOI: 10.4081/reumatismo.2016.870
5         Chow L, Chow TW, Chai J, Mattheos N. Bone stability around implants in elderly patients with reduced bone mineral density–a prospective study on mandibular overdentures. Clinical oral implants research. 2017;28(8):966-973. https://doi.org/10.1111/clr.12907.
6         Kanis JA. Assessment of osteoporosis at the primary health-care level. Technical report; 2007.
7         Handa R, Kalla AA, Maalouf G. Osteoporosis in developing countries. Best practice & research Clinical rheumatology. 2008;22(4):693-708. https://doi.org/10.1016/j.berh.2008.04.002.
8         Bazrafshan H, Qorbani M, Shadpour Rashti H, Aghaei M, Safari R. Prevalence of osteoporosis and its association with demographic characterirstics-Gorgan, Iran. Hormozgan Med J. 2011;15(1):56-62.
9         Yazdani S, Asli AI, Salemi A, Asli AI, Heidarnia MA, Sarbakhsh P. Determination of clinical decision rule for estimation of bone mineral density in women. Medical Principles and Practice. 2011;20(5):416-421. DOI: 10.1159/000542478.
10      Rosenblat J, Gregory J, Carvalho A, McIntyre R. Depression and disturbed bone metabolism: a narrative review of the epidemiological findings and postulated mechanisms. Current Molecular Medicine. 2016;16(2):165-178. DOI: 10.2174/1566524016666160126144303.
11      Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporosis international. 2005;16(5):447-455. https://doi.org/10.1007/s00198-004-1762-7.
12      Mezuk B, Eaton W, Golden S. Depression and osteoporosis: epidemiology and potential mediating pathways. Osteoporosis International. 2008;19(1):1-12. https://doi.org/10.1007/s00198-007-0449-2.
13      Chau K, Atkinson SA, Taylor VH. Are selective serotonin reuptake inhibitors a secondary cause of low bone density? Journal of osteoporosis. 2012;2012(1):1-7. https://doi.org/10.1155/2012/323061.
14      Ramasubbu R, Taylor VH, Samaan Z, Sockalingham S, Li M, Patten S, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Annals of Clinical Psychiatry. 2012;24(1):91-109. https://doi.org/10.1177/104012371202400110.
15      Kallala R, Barrow J, Graham SM, Kanakaris N, Giannoudis PV. The in vitro and in vivo effects of nicotine on bone, bone cells and fracture repair. Expert opinion on drug safety. 2013;12(2):209-233. https://doi.org/10.1517/14740338.2013.770471
16      Lee CW-S, Liao C-H, Lin C-L, Liang J-A, Sung F-C, Kao C-H, editors. Increased risk of osteoporosis in patients with depression: a population-based retrospective cohort study. Mayo Clinic Proceedings; 2015: 63-70. https://doi.org/10.1016/j.mayocp.2014.11.009.
17      Hsiao M-C, Liu C-Y, Wang C-J. Factors associated with low bone density among women with major depressive disorder. The International Journal of Psychiatry in Medicine. 2012;44(1):77-90. https://doi.org/10.2190/PM.44.1.f.
18      Sepehrmanesh Z, Zamani B, Pirasteh P, Rahimi H, Saei R. Prevalence of Depressive Symptoms in People With Osteoporosis Referred to the Bone Densitometry Center of a Hospital in Kashan. Qom University of Medical Sciences Journal. 2023;17:597-610. https://doi.org/10.32598/qums.17.2871.1.
19      Kaviani H, Seyfourian H, Sharifi V, Ebrahimkhani N. Reliability and validity of anxiety and depression hospital scales (HADS): Iranian patients with anxiety and depression disorders. 2009.
20      Kashfi SS, Abdollahi G, Hassanzadeh J, Mokarami H, Khani Jeihooni A. The relationship between osteoporosis and depression. Scientific Reports. 2022;12(1):11177. https://doi.org/10.1038/s41598-022-15248-w.
21      Cizza G. Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions. Dialogues in clinical neuroscience. 2011;13(1):73-87. https://doi.org/10.31887/DCNS.2011.13.1/gcizza.
22      Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S, et al. Low bone mass in premenopausal women with depression. Archives of Internal Medicine. 2007;167(21):2329-2336. doi:10.1001/archinte.167.21.2329.
23      Haliloğlu S, Uzkeser H, İçağasioğlu A. The Effect of Back Pain on Quality of Life, Sleep Quality and Depression in Patients with Postmenopausal Osteoporosis. Osteoporoz. 2014;20(1). DOI: 10.4274/tod.35229.
 
24      Saei Gharenaz M, Ozgoli G, Aghdashi MA, Salmany F. Relationship between depression and osteoporosis in women. Studies in Medical Sciences. 2015;26(1):10-16. http://umj.umsu.ac.ir/article-1-2716-en.html
25      Ljubicic Bistrovic I, Roncevic-Grzeta I, Crncevic-Orlic Z, Franciskovic T, Ljubicic R, Orlic A, et al. Connection of depression and bone loss in perimenopausal and postmenopausal women. Collegium antropologicum. 2012;36(4):1219-1223. PMID: 23390814.
26      Ozsoy S, Esel E, Turan MT, Kula M, Demir H, Kartalci S, et al. Is there any alteration in bone mineral density in patients with depression? Turk Psikiyatri Derg. 2005;16(2):77-82. PMID: 15981144.